{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"TScan Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"TCRX"},"Address":{"label":"Address","value":"830 WINTER STREET, WALTHAM, Massachusetts, 02451, United States"},"Phone":{"label":"Phone","value":"+1 857 399-9500"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors."},"CompanyUrl":{"label":"Company Url","value":"https://www.tscan.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Chrystal U. Louis","title":"Chief Medical Officer"},{"name":"Dawn Pinchasik","title":"Vice President-Clinical Development"},{"name":"Gavin MacBeath","title":"Chief Executive Officer & Director"},{"name":"Justin McCue","title":"Chief Technology Officer"},{"name":"Ray Lockard","title":"Senior VP-Technical Operations & Quality"},{"name":"Shrikanta Chattopadhya","title":"Senior Vice President-Translational Medicine"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}